CS
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America | Frontiers in immunology | 2024 | 9 | 34 | |||
Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonates | Clinical infectious diseases | 2023 | 9 | 7 | |||
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents : 5-year durability | Clinical microbiology and infection | 2023 | 54 | 0 | |||
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19 | Frontiers in immunology | 2023 | 132 | 15 | |||
Influence of circadian clocks on adaptive immunity and vaccination responses | Nature communications | 2023 | 182 | 36 | |||
C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates | Frontiers in immunology | 2023 | 9 | 7 | |||
Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumab | JAMA neurology | 2022 | 161 | 85 | |||
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years | Scientific reports | 2022 | 66 | 8 | |||
Swiss recommendations on perioperative antimicrobial prophylaxis in children | Swiss medical weekly | 2022 | 57 | 9 | |||
Transcriptomic signatures induced by the Ebola virus vaccine rVSV?G-ZEBOV-GP in adult cohorts in Europe, Africa, and North America : a molecular biomarker study | The Lancet microbe | 2022 | 75 | 20 | |||
Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls | Vaccine | 2022 | 25 | 0 | |||
Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence | 90th EAS (European Atherosclerosis Society) Congress | 2022 | 56 | 0 | |||
Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study | Clinical infectious diseases | 2022 | 146 | 23 | |||
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence | European journal of clinical investigation | 2022 | 332 | 66 | |||
Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis | International journal of molecular sciences | 2022 | 188 | 50 | |||
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs | Nature communications | 2022 | 197 | 100 | |||
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis | Frontiers in immunology | 2022 | 119 | 42 | |||
Is there a role for childhood vaccination against COVID-19? | Pediatric allergy and immunology | 2021 | 197 | 1 | |||
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine | Vaccines | 2021 | 91 | 34 | |||
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1 | EAS Congress 2021 | 2021 | 224 | 38 | |||
Rabies vaccination and multiple sclerosis relapse: A retrospective cohort study | Multiple Sclerosis and Related Disorders | 2021 | 217 | 86 | |||
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity | Cell reports | 2021 | 301 | 146 | |||
Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection | 2021 | 436 | 236 | |||
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms | Journal of clinical immunology | 2021 | 216 | 75 | |||
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study | Clinical Microbiology and Infection | 2021 | 312 | 152 | |||
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1 | European Journal of Clinical Investigation | 2021 | 276 | 199 | |||
Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel Disease | Digestion | 2021 | 67 | 12 | |||
Faudra-t-il vacciner les enfants contre le Covid-19 ? | Revue médicale suisse | 2021 | 45 | 19 | |||
Pneumococcal immunity and PCV13 vaccine response in SOT-candidates and recipients | Vaccine | 2021 | 170 | 0 | |||
Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settings | Journal of Clinical Medicine | 2021 | 263 | 115 | |||
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination | NPJ Vaccines | 2020 | 411 | 97 | |||
Validation of a commercially available SARS-CoV-2 serological immunoassay | Clinical Microbiology and Infection | 2020 | 420 | 215 | |||
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test | European Journal of Clinical Investigation | 2020 | 366 | 272 | |||
Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid tests | Journal of Clinical Medicine | 2020 | 291 | 144 | |||
Risk of MS relapse after yellow fever vaccination: A self-controlled case series | Neurology: Neuroimmunology & Neuroinflammation | 2020 | 170 | 57 | |||
A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner | Frontiers in immunology | 2020 | 197 | 67 | |||
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial | Clinical Microbiology and Infection | 2020 | 198 | 90 | |||
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series | mSphere | 2020 | 411 | 165 | |||
Missed vaccinations and critical care admission: all you may wish to know or rediscover-a narrative review | Intensive Care Medicine | 2020 | 439 | 0 | |||
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease | American Journal of Gastroenterology | 2019 | 249 | 0 | |||
Long-term Seroprotection of Varicella-zoster Immunization in Pediatric Liver Transplant Recipients | Transplantation | 2019 | 372 | 1 | |||
Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centers | Cell Reports | 2019 | 226 | 144 | |||
Detectable Vesicular Stomatitis Virus (VSV)-specific humoral and cellular immune responses following VSV-Ebola virus vaccination in humans | The Journal of Infectious Diseases | 2019 | 183 | 118 | |||
Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study | Rheumatology | 2019 | 255 | 0 | |||
Usefulness of a systematic approach at listing for vaccine prevention in solid organ transplant candidates | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2019 | 355 | 3 | |||
Neonatal T follicular helper cells are lodged in a pre-T follicular helper stage favoring innate over adaptive germinal center responses | Frontiers in Immunology | 2019 | 245 | 124 | |||
Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation | American Journal of Transplantation | 2019 | 447 | 4 | |||
Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial | Clinical Infectious Diseases | 2019 | 241 | 240 | |||
Site-specific DC surface signatures influence CD4+ T cell co-stimulation and lung-homing | Frontiers in Immunology | 2019 | 241 | 145 | |||
Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation | Frontiers in Immunology | 2019 | 224 | 107 | |||
Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland's largest pre-trial prison | Journal of Global Health | 2018 | 353 | 173 | |||
Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlan | Frontiers in Immunology | 2018 | 409 | 386 | |||
Prévention de la grippe en milieu de soins aigus : une intervention multimodale | Revue médicale suisse | 2018 | 409 | 136 | |||
Correlates of vaccine-induced protective immunity against Ebola virus disease | Seminars in Immunology | 2018 | 512 | 202 | |||
Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination | NPJ Vaccines | 2018 | 344 | 123 | |||
Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein 180L Single-Nucleotide Polymorphism Is Associated With Susceptibility to Recurrent Pneumococcal Lower Respiratory Tract Infections in Children | Frontiers in Immunology | 2018 | 451 | 198 | |||
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study | The Lancet Infectious Diseases | 2018 | 439 | 0 | |||
Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know? | Expert Review of Vaccines | 2018 | 310 | 0 | |||
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa | Science Translational Medicine | 2017 | 547 | 2 | |||
Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal Immunization | Clinical Infectious Diseases | 2017 | 562 | 212 | |||
Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey | PLOS ONE | 2017 | 448 | 174 | |||
Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementation | The Journal of Maternal - Fetal & Neonatal Medicine | 2017 | 408 | 0 | |||
Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis | Clinical infectious diseases | 2016 | 656 | 5 | |||
Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood | Proceedings of the National Academy of Sciences of the United States of America | 2016 | 589 | 2 | |||
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report | The New England journal of medicine | 2016 | 810 | 233 | |||
Reply to Abu Raya et al | Clinical infectious diseases | 2016 | 394 | 3 | |||
Vaccination in early life: standing up to the challenges | Current Opinion in Immunology | 2016 | 439 | 1 | |||
IL-36-Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid Cells | Journal of Immunology | 2016 | 478 | 2 | |||
Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes | The Journal of experimental medicine | 2016 | 655 | 4 | |||
The 2014–2015 Ebola outbreak in West Africa: Hands On | Antimicrobial Resistance and Infection Control | 2016 | 455 | 211 | |||
Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccine | Vaccine | 2016 | 520 | 3 | |||
Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study | Vaccine | 2015 | 465 | 0 | |||
The Nucleoprotein Is Required for Lymphocytic Choriomeningitis Virus-Based Vaccine Vector Immunogenicity | Journal of virology | 2015 | 525 | 2 | |||
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial | Lancet. Infectious diseases | 2015 | 633 | 0 | |||
Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases | Schweizerische medizinische Wochenschrift | 2015 | 561 | 1 | |||
Protective efficacy of individual CD8+ T cell specificities in chronic viral infection | The Journal of immunology | 2015 | 572 | 0 | |||
Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report | Lancet. Infectious diseases | 2015 | 633 | 1 | |||
Ebola vaccine R&D: Filling the knowledge gaps | Science translational medicine | 2015 | 453 | 1 | |||
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life | The Journal of immunology | 2015 | 553 | 2 | |||
Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of concept | Vaccine | 2015 | 560 | 124 | |||
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection | PLOS pathogens | 2015 | 620 | 269 | |||
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal study | Arthritis research & therapy | 2015 | 488 | 435 | |||
Bordetella holmesii: an under-recognised Bordetella species | Lancet. Infectious diseases | 2014 | 587 | 0 | |||
Diagnosis of whooping cough in Switzerland: differentiating Bordetella pertussis from Bordetella holmesii by polymerase chain reaction | PloS one | 2014 | 629 | 276 | |||
Influence of age, social patterns and nasopharyngeal carriage on antibodies to three conserved pneumococcal surface proteins (PhtD, PcpA and PrtA) in healthy young children | European journal of clinical microbiology & infectious diseases | 2013 | 593 | 251 | |||
Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children | The Pediatric infectious disease journal | 2013 | 570 | 0 | |||
Memory B cell compartment constitution and susceptibility to recurrent lower respiratory tract infections in young children | Journal of leukocyte biology | 2013 | 712 | 0 | |||
Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn | The Pediatric infectious disease journal | 2013 | 667 | 3 | |||
Tetanus immunity as a surrogate for past diphtheria-tetanus-pertussis immunization in migrant children | The Pediatric infectious disease journal | 2013 | 620 | 5 | |||
Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early life | PloS one | 2013 | 649 | 367 | |||
Calendrier vaccinal InfoVac pratique 2013 | Archives de pédiatrie | 2013 | 604 | 6 | |||
Homing and adhesion patterns determine the cellular composition of the bone marrow plasma cell niche | The Journal of immunology | 2012 | 553 | 0 | |||
Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine | Antiviral therapy | 2012 | 594 | 6 | |||
Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity* | HIV medicine | 2012 | 567 | 1 | |||
Use of pneumococcal polysaccharide vaccine in children: what is the evidence? | Current opinion in infectious diseases | 2012 | 508 | 0 | |||
Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in Switzerland | Clinical and vaccine immunology | 2012 | 615 | 0 | |||
Comparison of clinical presentation of respiratory tract infections in H1N1/09-positive and H1N1/09-negative patients | European journal of pediatrics | 2012 | 638 | 232 | |||
Bulletin InfoVac-France | Archives de pédiatrie | 2012 | 519 | 0 | |||
Bulletin InfoVac-France | Archives de pédiatrie | 2012 | 531 | 0 | |||
Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine | PloS one | 2012 | 707 | 302 | |||
Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemia | Clinical microbiology and infection | 2012 | 541 | 0 | |||
Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic | American journal of transplantation | 2012 | 709 | 1 | |||
Acceptability of maternal immunization against influenza: the critical role of obstetricians | Journal of maternal-fetal & neonatal medicine | 2012 | 662 | 0 | |||
Vaccination against seasonal flu in Switzerland: The indecision of pregnant women encouraged by healthcare professionals | Revue d'épidémiologie et de santé publique | 2012 | 658 | 3 | |||
Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants | The Journal of immunology | 2012 | 555 | 0 | |||
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients | HIV medicine | 2012 | 660 | 0 | |||
Bulletin InfoVac-France | Archives de pédiatrie | 2012 | 536 | 0 | |||
Successful serology-based intervention to increase protection against vaccine-preventable diseases in liver-transplanted children: a 19-yr review of the Swiss national reference center | Pediatric transplantation | 2012 | 627 | 0 | |||
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog | Journal of controlled release | 2012 | 598 | 1 | |||
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients | The oncologist | 2012 | 621 | 0 | |||
Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses | The Journal of immunology | 2012 | 599 | 0 | |||
Protective antibody responses to influenza A/H1N1/09 vaccination in children with celiac disease | Journal of pediatric gastroenterology and nutrition | 2012 | 579 | 408 | |||
Vaccinologie : nouvelles recommandations pour les rappels tétanos, diphtérie et coqueluche chez l'adulte | Revue médicale suisse | 2012 | 548 | 2 | |||
Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination program | Pharmacoepidemiology and drug safety | 2012 | 570 | 1 | |||
Bulletin spécial calendrier vaccinal | Archives de pédiatrie | 2011 | 476 | 2 | |||
Bulletin InfoVac-France | Archives de pédiatrie | 2011 | 520 | 0 | |||
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | 2011 | 961 | 558 | |||
Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticles | Bioconjugate chemistry | 2011 | 595 | 0 | |||
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children | Vaccine | 2011 | 582 | 0 | |||
Challenges in infant immunity: implications for responses to infection and vaccines | Nature immunology | 2011 | 431 | 0 | |||
Vaccination during pregnancy to protect infants against influenza: why and why not? | Vaccine | 2011 | 565 | 0 | |||
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | 2011 | 797 | 8 | |||
Bulletin spécial semaine de la vaccination: rougeole avril no 4/2011 1 | Archives de pédiatrie | 2011 | 367 | 0 | |||
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients | American journal of transplantation | 2011 | 603 | 0 | |||
ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia | Pharmacogenomics | 2011 | 897 | 6 | |||
Neonatal immunization: where do we stand? | Current opinion in infectious diseases | 2011 | 481 | 2 | |||
Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition? | Archives of neurology | 2011 | 595 | 0 | |||
Bulletin InfoVac-France | Archives de pédiatrie | 2011 | 507 | 0 | |||
The next decade of vaccines: societal and scientific challenges | Lancet | 2011 | 611 | 0 | |||
Immunity to pneumococcal surface proteins in children with community-acquired pneumonia: a distinct pattern of responses to pneumococcal choline-binding protein A | Clinical microbiology and infection | 2011 | 583 | 0 | |||
Bulletin infovac | Archives de pédiatrie | 2011 | 475 | 0 | |||
Improvement of measles immunity among migrant populations: lessons learned from a prevalence study in a Swiss prison | Schweizerische medizinische Wochenschrift | 2011 | 688 | 1 | |||
Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience | Ageing research reviews | 2011 | 614 | 1 002 | |||
Actualités vaccinologiques suisses: nouveaux vaccins glycoconjugués contre pneumocoques et méningocoques | Revue médicale suisse | 2011 | 440 | 1 | |||
Mode of action of adjuvants: implications for vaccine safety and design | Biologicals | 2010 | 573 | 0 | |||
Vaccinologie. Questions autour de la sécurité des vaccins adjuvantes contre la grippe A(H1N1) | Revue médicale suisse | 2010 | 464 | 1 | |||
Glycoconjugate vaccines and immune interference: A review | Vaccine | 2010 | 491 | 0 | |||
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity | Nature medicine | 2010 | 522 | 0 | |||
Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: waning of infancy-induced immune memory? | Vaccine | 2010 | 524 | 0 | |||
Chickenpox in a Swiss prison: susceptibility, post-exposure vaccination and control measures | Scandinavian journal of infectious diseases | 2010 | 671 | 3 | |||
Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy | The Journal of infectious diseases | 2010 | 472 | 0 | |||
Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children | Archives of disease in childhood | 2010 | 627 | 0 | |||
Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries | Medicine | 2010 | 537 | 1 | |||
Booster vaccination after neonatal priming with acellular pertussis vaccine | The Journal of pediatrics | 2010 | 538 | 0 | |||
B-cell responses to vaccination at the extremes of age | Nature reviews. Immunology | 2009 | 545 | 0 | |||
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials | Lancet | 2009 | 586 | 0 | |||
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines | Lancet | 2009 | 505 | 0 | |||
Impaired antibody response causes persistence of prototypic T cell-contained virus | PLoS biology | 2009 | 649 | 669 | |||
Comment on "Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironment where plasmablasts mature" | The Journal of immunology | 2009 | 485 | 0 | |||
Vaccinologie : quel rattrapage pour les patients avec des vaccinations inconnues ou incomplètes ? | Revue médicale suisse | 2009 | 458 | 0 | |||
Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of innovation theories | Vaccine | 2009 | 609 | 0 | |||
Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines | European journal of pediatrics | 2009 | 605 | 0 | |||
Immunization and transplantation--what is new and what is coming? | Pediatric transplantation | 2009 | 459 | 0 | |||
A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells | PloS one | 2009 | 631 | 373 | |||
Allergies et vaccins : distinguer le vrai du faux | Revue médicale suisse | 2009 | 429 | 0 | |||
Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland | The Pediatric infectious disease journal | 2009 | 579 | 0 | |||
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts | Blood | 2008 | 641 | 0 | |||
Recurrence of cardiorespiratory events following repeat DTaP-based combined immunization in very low birth weight premature infants | The Journal of pediatrics | 2008 | 541 | 0 | |||
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response | The Journal of immunology | 2008 | 552 | 2 | |||
Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children | The Pediatric infectious disease journal | 2008 | 601 | 3 | |||
Rougeole : diagnostic et prise en charge d'une maladie toujours d'actualité | Revue médicale suisse | 2008 | 574 | 0 | |||
Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody | Clinical infectious diseases | 2008 | 503 | 0 | |||
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells | Blood | 2008 | 623 | 0 | |||
Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization | The Journal of pediatrics | 2008 | 533 | 1 | |||
Actualités vaccinologiques pour 2008: quoi de neuf en Suisse ? | Revue médicale suisse | 2008 | 440 | 0 | |||
Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells | European Journal of Immunology | 2008 | 543 | 0 | |||
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae | Vaccine | 2008 | 592 | 1 | |||
Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant | PloS one | 2008 | 591 | 362 | |||
Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants | The Journal of pediatrics | 2008 | 549 | 0 | |||
Autoimmune diseases after adolescent or adult immunization: what should we expect? | CMAJ. Canadian Medical Association journal | 2007 | 492 | 233 | |||
Mechanisms underlying adverse reactions to vaccines | Journal of comparative pathology | 2007 | 525 | 0 | |||
Vaccine-induced immunity in children after orthotopic liver transplantation: a 12-yr review of the Swiss national reference center | Pediatric transplantation | 2007 | 569 | 0 | |||
Proximal splenic artery embolization for blunt splenic injury: clinical, immunologic, and ultrasound-Doppler follow-up | The Journal of trauma | 2007 | 482 | 0 | |||
Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005 | Vaccine | 2007 | 427 | 0 | |||
Atorvastatin treatment and vaccination efficacy | Journal of clinical pharmacology | 2007 | 561 | 0 | |||
Influence of anesthesia on immune responses and its effect on vaccination in children: review of evidence | Paediatric anaesthesia | 2007 | 580 | 2 | |||
Author's reply [Vaccination and anesthesia] | Paediatric anaesthesia | 2007 | 506 | 0 | |||
Vaccination des patients souffrant de maladies chroniques du foie | Revue médicale suisse | 2007 | 455 | 2 | |||
The challenges of vaccine responses in early life: selected examples | Journal of comparative pathology | 2007 | 521 | 0 | |||
Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells | Journal of virology | 2007 | 511 | 353 | |||
Vaccinologie : Plan de vaccination suisse 2007 : première lecture | Revue médicale suisse | 2007 | 457 | 4 | |||
Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions | The Pediatric infectious disease journal | 2007 | 471 | 0 | |||
Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection? | Clinical and vaccine immunology | 2006 | 654 | 445 | |||
Actualités vaccinologiques 2005 : nouvelle catégorie de recommandations pour une protection vaccinale optimale | Revue médicale suisse | 2006 | 454 | 0 | |||
Enhanced chickenpox exanthema in vaccine injection site | Scandinavian journal of infectious diseases | 2006 | 455 | 0 | |||
Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins | Vaccine | 2006 | 488 | 0 | |||
Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy | European Journal of Immunology | 2006 | 477 | 0 | |||
Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival | The Journal of immunology | 2006 | 536 | 287 | |||
Les vaccins sous haute surveillance : effets indésirables des vaccins : questions posée et réponses apportées par InfoVac | Archives de pédiatrie | 2006 | 457 | 1 | |||
B. Zinka et al., Unexplained cases of sudden infant death shortly after hexavalent vaccination | Vaccine | 2006 | 569 | 0 | |||
Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan | TM & IH. Tropical medicine and international health | 2006 | 496 | 0 | |||
Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infants | The Journal of infectious diseases | 2006 | 527 | 323 | |||
Immunisation of premature infants | Archives of disease in childhood | 2006 | 440 | 0 | |||
Vaccinologie | Revue médicale suisse | 2005 | 407 | 0 | |||
Die Folgen einer ungenügenden Herdimmunität bei «pädiatrischen» Infektionskrankheiten - Beispiel einer Masernepidemie | Therapeutische Umschau | 2005 | 606 | 0 | |||
How do physicians immunize their own children? Differences among pediatricians and nonpediatricians | Pediatrics | 2005 | 477 | 0 | |||
Can successful vaccines teach us how to induce efficient protective immune responses? | Nature medicine | 2005 | 518 | 0 | |||
Infections récurrentes des voies respiratoires inférieures de l'enfant : quand et comment les investiguer ? | Revue médicale suisse | 2005 | 513 | 0 | |||
Vaccine safety controversies and the future of vaccination programs | The Pediatric infectious disease journal | 2005 | 582 | 0 | |||
La vaccinologie, une science neuve aux prises avec les croyances | Revue médicale suisse | 2005 | 410 | 0 | |||
Les adjuvants vaccinaux et la myofasciite à macrophages | Archives de pédiatrie | 2005 | 532 | 1 | |||
The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703 | FEMS immunology and medical microbiology | 2005 | 512 | 244 | |||
The advantage of mucosal immunization for polysaccharide-specific memory responses in early life | European Journal of Immunology | 2005 | 400 | 0 | |||
Immunisation, immunomodulation et prévention des infections respiratoires | Revue médicale suisse | 2005 | 445 | 0 | |||
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety | American journal of public health | 2004 | 516 | 558 | |||
Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type | Vaccine | 2004 | 573 | 0 | |||
Influence of complement C3 amount on IgG responses in early life: immunization with C3b-conjugated antigen increases murine neonatal antibody responses | Vaccine | 2004 | 525 | 0 | |||
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response | Vaccine | 2004 | 569 | 0 | |||
Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory events | The Journal of pediatrics | 2004 | 482 | 0 | |||
Genetic regulation of immune responses to vaccines in early life | Genes and immunity | 2004 | 482 | 0 | |||
Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infection | Microbes and infection | 2004 | 474 | 0 | |||
Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheres | The Journal of immunology | 2004 | 582 | 648 | |||
Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults | Vaccine | 2004 | 511 | 0 | |||
Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic mice | The Journal of immunology | 2004 | 550 | 0 | |||
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeys | The American journal of tropical medicine and hygiene | 2004 | 867 | 1 013 | |||
Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants | Vaccine | 2003 | 412 | 0 | |||
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium) | Vaccine | 2003 | 509 | 0 | |||
CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal mice | Vaccine | 2003 | 565 | 0 | |||
CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particles | Virology | 2003 | 549 | 316 | |||
Les adjuvants vaccinaux et la myofasciite à macrophages | Bulletin de l'Académie nationale de médecine | 2003 | 527 | 0 | |||
Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate | Vaccine | 2003 | 529 | 0 | |||
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications | The Journal of experimental medicine | 2003 | 455 | 839 | |||
Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens | The Journal of immunology | 2003 | 479 | 414 | |||
Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers | The Journal of immunology | 2003 | 526 | 499 | |||
Prévention vaccinale chez les adolescents : et s'il suffisait d'y penser ? | Médecine et hygiène | 2003 | 401 | 2 | |||
Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cells | The Journal of immunology | 2002 | 519 | 242 | |||
Polémiques de sécurité vaccinale : fin d'une histoire ou histoire sans fin ? | Médecine et hygiène | 2002 | 349 | 0 | |||
Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccines | European Journal of Immunology | 2002 | 493 | 2 | |||
Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice | Infection and immunity | 2002 | 474 | 248 | |||
Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis | Infection and immunity | 2002 | 524 | 242 | |||
Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infection | The Journal of infectious diseases | 2002 | 529 | 0 | |||
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination | The Journal of immunology | 2002 | 506 | 285 | |||
Epidemiology of herpes simplex virus in children by detection of specific antibodies in saliva | The Pediatric infectious disease journal | 2001 | 507 | 0 | |||
Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vector | Virology | 2001 | 544 | 281 | |||
Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies | FEMS immunology and medical microbiology | 2001 | 493 | 247 | |||
Neonatal and early life vaccinology | Vaccine | 2001 | 543 | 0 | |||
Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life | European Journal of Immunology | 2001 | 427 | 2 | |||
The search for novel adjuvants for early life vaccinations: can "danger" motifs show us the way? | Archivum Immunologiae et Therapiae Experimentalis | 2001 | 403 | 0 | |||
Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens | Immunology | 2001 | 530 | 480 | |||
Infections récidivantes de l'enfant : quel dépistage immunitaire ? | Archives de pédiatrie | 2001 | 434 | 0 | |||
Nosocomial outbreak of multiple bloodborne viral infections | The Journal of infectious diseases | 2001 | 550 | 216 | |||
How to improve communication on vaccine issues at the national level? INFOVAC-PED: an example from Switzerland | Vaccine | 2001 | 480 | 0 | |||
Detection of enteroviruses in the cerebrospinal fluid by polymerase chain reaction: prospective study of impact on the management of hospitalized children | Clinical pediatrics | 2000 | 509 | 0 | |||
Expression of MHC class II molecules contributes to lipopolysaccharide responsiveness | European Journal of Immunology | 2000 | 422 | 0 | |||
Vaccin contre la fièvre jaune : formellement contre-indiqué chez les transplantés | Médecine et hygiène | 2000 | 417 | 0 | |||
A brief view of known landmarks reorientates path integration in hamsters | Naturwissenschaften | 2000 | 545 | 0 | |||
Non, le vaccin contre l'hépatite B ne provoque pas la sclérose en plaques : retour sur un psychodrame collectif | La Recherche | 2000 | 515 | 1 | |||
Quand et comment vacciner les prématurés ? | Médecine et hygiène | 2000 | 354 | 0 | |||
Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice | European Journal of Immunology | 1999 | 478 | 0 | |||
Antigen-Presentation Systems, Immunomodulators, and Immune Responses to Vaccines | Handbook of experimental pharmacology | 1999 | 346 | 0 | |||
Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis | Lancet | 1999 | 472 | 0 | |||
CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming | The Journal of immunology | 1999 | 433 | 160 | |||
Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group | AIDS | 1998 | 420 | 0 | |||
Determinants of infant responses to vaccines in presence of maternal antibodies | Vaccine | 1998 | 436 | 0 | |||
Die Impfung gegen Hepatitis B | Sozial- und Präventivmedizin | 1998 | 437 | 0 | |||
Quel avenir pour les vaccins ? | Revue médicale de la Suisse romande | 1998 | 423 | 0 | |||
Procalcitonin is a marker of severity of renal lesions in pyelonephritis | Pediatrics | 1998 | 515 | 1 | |||
Hépatite B et sclérose en plaques : comment répondre aux inquiétudes du public ? | Médecine et hygiène | 1998 | 413 | 0 | |||
Influenza immunization: improving compliance of healthcare workers | Infection control and hospital epidemiology | 1998 | 481 | 0 | |||
Immunity in early life | Immunology today | 1998 | 448 | 0 | |||
New challenges for global immunization | Symposium in Immunology: Vol. VII : Vaccination | 1998 | 441 | 0 | |||
Immunity in early life : an introduction [Proceedings of the International Symposium on Immunity in Early Life. Annecy, France, 17-19 November 1997] | Vaccine | 1998 | 444 | 0 | |||
Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells? | Vaccine | 1998 | 499 | 0 | |||
Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice | European Journal of Immunology | 1998 | 515 | 0 | |||
Vaccination des sujets présentant un problème médical : précautions, contre-indications | Revue médicale de la Suisse romande | 1998 | 429 | 0 | |||
Optimization of vaccine responses in early life: the role of delivery systems and immunomodulators | Immunology and cell biology | 1998 | 443 | 437 | |||
Maternal immunity and infant responses to immunization : actors influencing infant responses | Preclinical and clinical development of new vaccines : proceedings of a symposium, Institut Pasteur, Paris, France, 27-28 May 1997 | 1998 | 362 | 0 | |||
Les vaccins contre l'hépatite B | Sozial- und Präventivmedizin | 1998 | 488 | 0 | |||
Le développement de nouveaux vaccins à usage pédiatrique : progrès et défis | Revue médicale de la Suisse romande | 1998 | 424 | 0 | |||
CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice | Proceedings of the National Academy of Sciences of the United States of America | 1998 | 514 | 665 | |||
Cervical lymphadenitis caused by Mycobacterium genavense in a healthy child | The Pediatric infectious disease journal | 1996 | 589 | 0 | |||
Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters | The Journal of biological chemistry | 1994 | 546 | 0 | |||
Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y | Proceedings of the National Academy of Sciences of the United States of America | 1994 | 557 | 0 | |||
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer | Molecular and cellular biology | 1993 | 548 | 0 | |||
Septicémie à anaérobes après infections oropharyngées (septicémie post-angine de Lemierre): un syndrome oublié | Schweizerische medizinische Wochenschrift | 1983 | 709 | 0 |